Bipolar spectrum disorders in patients diagnosed with velo-cardio- facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted
	Citation Map



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Papolos, D. F.
	Articles by Shprintzen, R. J.
	Search for Related Content



	PubMed Citation
	Articles by Papolos, D. F.
	Articles by Shprintzen, R. J.



	Bipolar Disorder
	Genetics

Am J Psychiatry 1996; 153:1541-1547
Copyright © 1996 by American Psychiatric Association

REGULAR ARTICLES

Bipolar spectrum disorders in patients diagnosed with velo-cardio- facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?

DF Papolos, GL Faedda, S Veit, R Goldberg, B Morrow, R Kucherlapati and RJ Shprintzen
Department of Psychiatry, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY 10461, USA.

OBJECTIVE: The purpose of this study was to conduct a systematic assessment of psychiatric illness in patients diagnosed with velo- cardio-facial syndrome, a genetic syndrome that involves over 40 somatic anomalies, learning disabilities, and behavioral disorders and is associated with a microdeletion on chromosome 22q11. METHOD: Subjects were referred for psychiatric diagnostic evaluation without regard to age or previous psychiatric history. In order to establish DSM-III-R consensus clinical diagnoses for patients who ranged in age from 5 to 34 years, the Diagnostic Interview for Children and Adolescents--Revised or the Structured Clinical Interview for DSM-III-R (SCID) was used. A review of available medical and psychiatric records and a clinical interview performed by two research psychiatrists to validate specific symptoms and syndromes reported in the Diagnostic Interview for Children and Adolescents--Revised and the SCID were used to elucidate the chronological appearance and duration of symptoms. RESULTS: Sixty-four percent (N = 16 of 25) of this unselected series of patients with velo-cardio-facial syndrome met DSM-III-R criteria for a spectrum of bipolar disorders with full syndromal onset in late childhood or early adolescence (mean age at onset = 12 years, SD = 3). In addition, 20% (N = 5) met DSM-III-R criteria for attention deficit hyperactivity disorder (ADHD), while 16% (N = 4) met criteria for attention deficit disorder without hyperactivity. In contrast to previous reports of a high prevalence of schizophrenia, none of the patients was diagnosed with schizophrenia, and only four had psychotic symptoms during a phase of their illness, all in their 20s or 30s. CONCLUSIONS: Given that the prevalence of bipolar disorder in the general population is estimated to be 1.5% and that the average age at onset is 24, these findings support an unusually strong association between velo-cardio-facial syndrome and early-onset bipolar disorder and suggest that a gene deleted at the 22q11 chromosomal locus may be involved in its pathogenesis. If confirmed, these findings may provide a new and fruitful line of investigation into the molecular basis of bipolar spectrum disorders.

This article has been cited by other articles:

C. E. Bearden, T. G.M. van Erp, R. A. Dutton, A. D. Lee, T. J. Simon, T. D. Cannon, B. S. Emanuel, D. McDonald-McGinn, E. H. Zackai, and P. M. Thompson
Alterations in Midline Cortical Thickness and Gyrification Patterns Mapped in Children with 22q11.2 Deletions
Cereb Cortex, May 14, 2008; (2008) bhn064v1.
[Abstract] [Full Text] [PDF]

N. M. Williams, B. Glaser, N. Norton, H. Williams, T. Pierce, V. Moskvina, S. Monks, J. Del Favero, D. Goossens, D. Rujescu, et al.
Strong evidence that GNB1L is associated with schizophrenia
Hum. Mol. Genet., February 14, 2008; 17(4): 555 - 566.
[Abstract] [Full Text] [PDF]

H. J. Williams, M. J. Owen, and M. C. O'Donovan
Is COMT a Susceptibility Gene for Schizophrenia?
Schizophr Bull, May 1, 2007; 33(3): 635 - 641.
[Abstract] [Full Text] [PDF]

L. E. Campbell, E. Daly, F. Toal, A. Stevens, R. Azuma, M. Catani, V. Ng, T. van Amelsvoort, X. Chitnis, W. Cutter, et al.
Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel-based morphometry MRI study
Brain, May 1, 2006; 129(5): 1218 - 1228.
[Abstract] [Full Text] [PDF]

N. Hiroi, H. Zhu, M. Lee, B. Funke, M. Arai, M. Itokawa, R. Kucherlapati, B. Morrow, T. Sawamura, and S. Agatsuma
A 200-kb region of human chromosome 22q11.2 confers antipsychotic-responsive behavioral abnormalities in mice
PNAS, December 27, 2005; 102(52): 19132 - 19137.
[Abstract] [Full Text] [PDF]

K. D. BAKER and D. H. SKUSE
Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group
The British Journal of Psychiatry, February 1, 2005; 186(2): 115 - 120.
[Abstract] [Full Text] [PDF]

K. R. R. Krishnan
Psychiatric and Medical Comorbidities of Bipolar Disorder
Psychosom Med, January 1, 2005; 67(1): 1 - 8.
[Abstract] [Full Text] [PDF]

T. van Amelsvoort, E. Daly, J. Henry, D. Robertson, V. Ng, M. Owen, K. C. Murphy, and D. G. M. Murphy
Brain Anatomy in Adults With Velocardiofacial Syndrome With and Without Schizophrenia: Preliminary Results of a Structural Magnetic Resonance Imaging Study
Arch Gen Psychiatry, November 1, 2004; 61(11): 1085 - 1096.
[Abstract] [Full Text] [PDF]

C. E. Bearden, A. F. Jawad, D. R. Lynch, S. Sokol, S. J. Kanes, D. M. McDonald-McGinn, S. C. Saitta, S. E. Harris, E. Moss, P. P. Wang, et al.
Effects of a Functional COMT Polymorphism on Prefrontal Cognitive Function in Patients With 22q11.2 Deletion Syndrome
Am J Psychiatry, September 1, 2004; 161(9): 1700 - 1702.
[Abstract] [Full Text] [PDF]

W. R. Kates, C. P. Burnette, B. A. Bessette, B. S. Folley, L. Strunge, E. W. Jabs, and G. D. Pearlson
Frontal and Caudate Alterations in Velocardiofacial Syndrome (Deletion at Chromosome 22q11.2)
J Child Neurol, May 1, 2004; 19(5): 337 - 342.
[Abstract] [PDF]

D. IVANOV, G. KIROV, N. NORTON, H.J. WILLIAMS, N.M. WILLIAMS, I. NIKOLOV, R. TZWETKOVA, S. M. STAMBOLOVA, K. C. MURPHY, D. TONCHEVA, et al.
Chromosome 22q11 deletions, velo-cardio-facial syndrome and early-onset psychosis: Molecular genetic study
The British Journal of Psychiatry, November 1, 2003; 183(5): 409 - 413.
[Abstract] [Full Text] [PDF]

M. C. O'Donovan, N. M. Williams, and M. J. Owen
Recent advances in the genetics of schizophrenia
Hum. Mol. Genet., October 15, 2003; 12(90002): R125 - 133.
[Abstract] [Full Text] [PDF]

N. Barnea-Goraly, V. Menon, B. Krasnow, A. Ko, A. Reiss, and S. Eliez
Investigation of White Matter Structure in Velocardiofacial Syndrome: A Diffusion Tensor Imaging Study
Am J Psychiatry, October 1, 2003; 160(10): 1863 - 1869.
[Abstract] [Full Text] [PDF]

A. Baldini
DiGeorge syndrome: the use of model organisms to dissect complex genetics
Hum. Mol. Genet., October 1, 2002; 11(20): 2363 - 2369.
[Abstract] [Full Text] [PDF]

R. Paylor, K. L. McIlwain, R. McAninch, A. Nellis, L. A. Yuva-Paylor, A. Baldini, and E. A. Lindsay
Mice deleted for the DiGeorge/velocardiofacial syndrome region show abnormal sensorimotor gating and learning and memory impairments
Hum. Mol. Genet., November 1, 2001; 10(23): 2645 - 2650.
[Abstract] [Full Text] [PDF]

K.C. MURPHY and M.J. OWEN
Velo-cardio-facial syndrome: a model for understanding the genetics and pathogenesis of schizophrenia
The British Journal of Psychiatry, November 1, 2001; 179(5): 397 - 402.
[Abstract] [Full Text] [PDF]

A. K. Percy and C. B. Nemeroff
Chromosome 22q and the mind-brain interface: Bedside to bench to bedside
Neurology, August 14, 2001; 57(3): 377 - 378.
[Full Text] [PDF]

W. D. Graf, A. S. Unis, C. M. Yates, S. Sulzbacher, M. B. Dinulos, R. M. Jack, K. A. Dugaw, M. N. Paddock, and W. W. Parson
Catecholamines in patients with 22q11.2 deletion syndrome and the low-activity COMT polymorphism
Neurology, August 14, 2001; 57(3): 410 - 416.
[Abstract] [Full Text] [PDF]

T. V. AMELSVOORT, E. DALY, D. ROBERTSON, J. SUCKLING, V. NG, H. CRITCHLEY, M. J. OWEN, J. HENRY, K. C. MURPHY, and D. G. M. MURPHY
Structural brain abnormalities associated with deletion at chromosome 22q11: Quantitative neuroimaging study of adults with velo-cardio-facial syndrome
The British Journal of Psychiatry, May 1, 2001; 178(5): 412 - 419.
[Abstract] [Full Text] [PDF]

S. Eliez, S. E. Antonarakis, M. A. Morris, S. P. Dahoun, and A. L. Reiss
Parental Origin of the Deletion 22q11.2 and Brain Development in Velocardiofacial Syndrome: A Preliminary Study
Arch Gen Psychiatry, January 1, 2001; 58(1): 64 - 68.
[Abstract] [Full Text] [PDF]

P. J. Scambler
The 22q11 deletion syndromes
Hum. Mol. Genet., October 1, 2000; 9(16): 2421 - 2426.
[Abstract] [Full Text] [PDF]

S. F. Stoltenberg and M. Burmeister
Recent progress in psychiatric genetics--some hope but no hype
Hum. Mol. Genet., April 1, 2000; 9(6): 927 - 935.
[Abstract] [Full Text] [PDF]

L. Tarantino and M. Bucan
Dissection of behavior and psychiatric disorders using the mouse as a model
Hum. Mol. Genet., April 1, 2000; 9(6): 953 - 965.
[Abstract] [Full Text] [PDF]

S. Sugama, T. Namihira, R. Matsuoka, N. Taira, Y. Eto, and K. Maekawa
Psychiatric inpatients and chromosome deletions within 22q11.2
J. Neurol. Neurosurg. Psychiatry, December 1, 1999; 67(6): 803 - 806.
[Abstract] [Full Text] [PDF]

P. T. Mannisto and S. Kaakkola
Catechol-O-methyltransferase (COMT): Biochemistry, Molecular Biology, Pharmacology, and Clinical Efficacy of the New Selective COMT Inhibitors
Pharmacol. Rev., December 1, 1999; 51(4): 593 - 628.
[Abstract] [Full Text] [PDF]

K. C. Murphy, L. A. Jones, and M. J. Owen
High Rates of Schizophrenia in Adults With Velo-Cardio-Facial Syndrome
Arch Gen Psychiatry, October 1, 1999; 56(10): 940 - 945.
[Abstract] [Full Text] [PDF]

L. Edelmann, R. K. Pandita, E. Spiteri, B. Funke, R. Goldberg, N. Palanisamy, R. S. K. Chaganti, E. Magenis, R. J. Shprintzen, and B. E. Morrow
A common molecular basis for rearrangement disorders on chromosome 22q11
Hum. Mol. Genet., July 1, 1999; 8(7): 1157 - 1167.
[Abstract] [Full Text] [PDF]

J. A. Gogos, M. Morgan, V. Luine, M. Santha, S. Ogawa, D. Pfaff, and M. Karayiorgou
Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior
PNAS, August 18, 1998; 95(17): 9991 - 9996.
[Abstract] [Full Text] [PDF]

S. E. McCandless, J. A. Scott, and N. H. Robin
Deletion 22q11: A Newly Recognized Cause of Behavioral and Psychiatric Disorders
Arch Pediatr Adolesc Med, May 1, 1998; 152(5): 481 - 484.
[Abstract] [Full Text] [PDF]

M. Karayiorgou, M. Altemus, B. L. Galke, D. Goldman, D. L. Murphy, J. Ott, and J. A. Gogos
Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive�disorder
PNAS, April 29, 1997; 94(9): 4572 - 4575.
[Abstract] [Full Text] [PDF]

Get information about faster international access.